AMP-224

Generic Name
AMP-224
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
1422184-00-6
Unique Ingredient Identifier
SKF3JJJ5QA
Associated Conditions
-
Associated Therapies
-

AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer

First Posted Date
2014-11-24
Last Posted Date
2019-02-22
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
17
Registration Number
NCT02298946
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-05-12
Last Posted Date
2016-09-05
Lead Sponsor
MedImmune LLC
Target Recruit Count
44
Registration Number
NCT01352884
Locations
🇺🇸

Karmanos Cancer Institute, Detroit, Michigan, United States

🇺🇸

Sarah Cannon Research Institute, Nashville, Tennessee, United States

🇺🇸

Carolina BioOncology Institute, Huntersville, North Carolina, United States

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath